ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer

Epidermal growth factor receptor (EGFR) activating mutations occur in approximately 50% of East Asian patients with non‐small‐cell lung cancer (NSCLC) and confer sensitivity to tyrosine kinase inhibitors (TKIs). ASP8273 is an irreversible EGFR‐TKI, given orally, that inhibits EGFR activating mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Azuma, Koichi, Nishio, Makoto, Hayashi, Hidetoshi, Kiura, Katsuyuki, Satouchi, Miyako, Sugawara, Shunichi, Hida, Toyoaki, Iwamoto, Yasuo, Inoue, Akira, Takeda, Koji, Ikeda, Satoshi, Nakagawa, Tomoki, Takeda, Kentaro, Asahina, Seitaro, Komatsu, Kanji, Morita, Satoshi, Fukuoka, Masahiro, Nakagawa, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113441/
https://ncbi.nlm.nih.gov/pubmed/29807396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13651
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados